cardiovascular-agents and Cushing-Syndrome

cardiovascular-agents has been researched along with Cushing-Syndrome* in 2 studies

Reviews

1 review(s) available for cardiovascular-agents and Cushing-Syndrome

Article	Year
Dilated cardiomyopathy as a presenting feature of Cushing's syndrome. Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:10 Cardiovascular complications, including cardiomegaly, myocardial ischemia and left ventricular hypertrophy, are some of the major determinants of the mortality rate in patients with Cushing's syndrome. We herein report the case of a patient with Cushing's syndrome caused by an adrenal adenoma who presented with congestive heart failure secondary to dilated cardiomyopathy. Follow-up echocardiography showed a marked improvement in the left ventricular cardiac function, and the plasma B-type natriuretic peptide (BNP) levels regressed after successful treatment. "Reversible" dilated cardiomyopathy is rarely associated with Cushing's syndrome; however, it should be recognized. Administering appropriate treatment in a timely manner can reverse this cardiomyopathy along with the other symptoms of Cushing's syndrome. Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenalectomy; Aged; Biomarkers; Cardiomyopathy, Dilated; Cardiovascular Agents; Circadian Rhythm; Cushing Syndrome; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Heart Failure; Humans; Hydrocortisone; Natriuretic Peptide, Brain; Remission Induction	2013

Article

Year

Dilated cardiomyopathy as a presenting feature of Cushing's syndrome.

Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:10

Cardiovascular complications, including cardiomegaly, myocardial ischemia and left ventricular hypertrophy, are some of the major determinants of the mortality rate in patients with Cushing's syndrome. We herein report the case of a patient with Cushing's syndrome caused by an adrenal adenoma who presented with congestive heart failure secondary to dilated cardiomyopathy. Follow-up echocardiography showed a marked improvement in the left ventricular cardiac function, and the plasma B-type natriuretic peptide (BNP) levels regressed after successful treatment. "Reversible" dilated cardiomyopathy is rarely associated with Cushing's syndrome; however, it should be recognized. Administering appropriate treatment in a timely manner can reverse this cardiomyopathy along with the other symptoms of Cushing's syndrome.

Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenalectomy; Aged; Biomarkers; Cardiomyopathy, Dilated; Cardiovascular Agents; Circadian Rhythm; Cushing Syndrome; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Heart Failure; Humans; Hydrocortisone; Natriuretic Peptide, Brain; Remission Induction

2013

Other Studies

1 other study(ies) available for cardiovascular-agents and Cushing-Syndrome

Article	Year
[Diagnostic value of urinary & blood corticosteroids in the Cushing syndrome]. Il Progresso medico, 1957, Sep-30, Volume: 13, Issue:18 Topics: Adrenal Cortex Hormones; Cardiovascular Agents; Cushing Syndrome; Dermatologic Agents; Glucocorticoids; Humans	1957